Related references
Note: Only part of the references are listed.The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre-insertion and post-insertion methods for brain delivery in normal mice
Amin Mehrabian et al.
IET NANOBIOTECHNOLOGY (2023)
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Yun Chang et al.
NATURE COMMUNICATIONS (2023)
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang et al.
NATURE COMMUNICATIONS (2023)
Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma
Yang Hu et al.
ACTA BIOMATERIALIA (2022)
Targeting immunoliposomes to EGFR-positive glioblastoma
B. Kasenda et al.
ESMO OPEN (2022)
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S. Alghamri et al.
ACS NANO (2022)
Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
Rubiya Khursheed et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Contemporary RNA Therapeutics for Glioblastoma
Kaitlyn Melnick et al.
NEUROMOLECULAR MEDICINE (2022)
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Obaid Afzal et al.
NANOMATERIALS (2022)
Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications
Nicholas C. Allen et al.
NANOMATERIALS (2022)
Nanoscale Drug Delivery Systems in Glioblastoma
Zihao Liu et al.
NANOSCALE RESEARCH LETTERS (2022)
Angiopep-2 modi fi ed lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB
Jingjing Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture
Guliz Ak et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Nanogold-based materials in medicine: from their origins to their future
Tania Ferreira-Goncalves et al.
NANOMEDICINE (2021)
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
Ying Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update
Bijuli Rabha et al.
POLYMERS (2021)
Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme
Benita Ortega-Berlanga et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)
Enhanced Anticancer Response of Curcumin- and Piperine-Loaded Lignin-g-p (NIPAM-co-DMAEMA) Gold Nanogels against U-251 MG Glioblastoma Multiforme
Bilal Javed et al.
BIOMEDICINES (2021)
Potential Use of Nitrogen-Doped Carbon Nanotube Sponges as Payload Carriers Against Malignant Glioma
Aleli Salazar et al.
NANOMATERIALS (2021)
Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma
Panpan Song et al.
BIOMACROMOLECULES (2021)
Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma
Henry Ruiz-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
Andrea Comba et al.
FRONTIERS IN ONCOLOGY (2021)
The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
Jun Wu
JOURNAL OF PERSONALIZED MEDICINE (2021)
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors
Peter A. Bielecki et al.
NANOSCALE HORIZONS (2021)
Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy
Juan Aparicio-Blanco et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Advancement in nanogel formulations provides controlled drug release
Shayan Ahmed et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Trang Thi Thu Nguyen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Gold Nanoparticles in Glioma Theranostics
Mohammad Norouzi
PHARMACOLOGICAL RESEARCH (2020)
Carbon nanostructures: The drug and the delivery system for brain disorders
T. K. Henna et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
Jason V. Gregory et al.
NATURE COMMUNICATIONS (2020)
Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles
Dana Marekova et al.
ANTICANCER RESEARCH (2020)
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Sebastian Scioli Montoto et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao et al.
THERANOSTICS (2020)
Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
Anubhab Mukherjee et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Visualization of spatiotemporal dynamics of human glioma stem cell invasion
Ryota Tamura et al.
MOLECULAR BRAIN (2019)
Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo
Kristen L. Kozielski et al.
BIOMATERIALS (2019)
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma
Sang-Soo Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Mei Songbo et al.
TOXICOLOGY LETTERS (2019)
Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles
Zhou Yu et al.
MOLECULAR PHARMACEUTICS (2019)
Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment
Sophie Pinel et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Mesoporous silica nanoparticles for therapeutic/diagnostic applications
Samira Jafari et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma
Alastair Droop et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound
Daniel Coluccia et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma
Yanyu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma
M. A. Rajora et al.
CHEMICAL SCIENCE (2017)
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
Jennifer L. Clarke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Therapeutic options in recurrent glioblastoma-An update
Katharina Seystahl et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Interactions between carbon nanotubes and bioactives: a drug delivery perspective
Neelesh Kumar Mehra et al.
DRUG DISCOVERY TODAY (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
New progress and prospects: The application of nanogel in drug delivery
Hui Zhang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma
Mihaela Aldea et al.
PHARMACEUTICAL RESEARCH (2016)
Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme
Kairong Shi et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Controlled drug delivery systems: Past forward and future back
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2014)
Mechanism Study of Cellular Uptake and Tight Junction Opening Mediated by Goblet Cell-Specific Trimethyl Chitosan Nanoparticles
Jian Zhang et al.
MOLECULAR PHARMACEUTICS (2014)
Multiwalled Carbon Nanotubes Hinder Microglia Function Interfering with Cell Migration and Phagocytosis
Juan C. Villegas et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Hollow superparamagnetic iron oxide nanoshells as a hydrophobic anticancer drug carrier: intracelluar pH-dependent drug release and enhanced cytotoxicity
Xiao-Ming Zhu et al.
NANOSCALE (2012)
Nanoparticles in cellular drug delivery
Amir H. Faraji et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study
Christoph P. Beier et al.
BMC CANCER (2009)
Role of Convective Flow in Carmustine Delivery to a Brain Tumor
Davis Yohanes Arifin et al.
PHARMACEUTICAL RESEARCH (2009)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)